FDA Approves PREGABALIN — Aurobindo Pharma Limited

Oncedem Pharmaceuticals (formerly Aurobindo Pharma) announced the approval of its generic pregabalin tablets, a move expected to position the company as a major player in the US market for this widely prescribed neurology medication. The ANDA approval challenges the pricing power of established manufacturers and allows Oncedem to capture additional market share from top-selling branded competitors.